Medical imaging was not a headline category at HIMSS 2026 the way agentic AI or revenue cycle automation were, but the announcements that emerged from Las Vegas last week reflected a market in a meaningful transition. The enterprise imaging vendors that dominated last November’s RSNA annual meeting arrived at HIMSS26 carrying a consistent message: the era of standalone AI algorithms is giving way to integrated, cloud-native platforms designed to support radiologists, pathologists, and cardiologists across distributed health system networks.


HotSpot Take

HIMSS26 confirmed what RSNA 2025 signaled: medical imaging AI has moved from algorithm showcases to enterprise infrastructure — while Aidoc’s 200,000-scans-per-day deployment data put clinical scale in sharp relief.


Philips Connects Diagnostics Across the Enterprise

A wide-angle view of the HIMSS26 exhibition floor in Las Vegas, with healthcare technology vendors and attendees visible across a busy conference hall, including a partial view of the Philips booth.

The HIMSS26 exhibition floor in Las Vegas drew thousands of healthcare technology professionals March 9–12, 2026. Photo courtesy of HIMSS26.

Royal Philips highlighted two interconnected capabilities at HIMSS26: enterprise patient monitoring for longitudinal care intelligence and Integrated Diagnostics, which brings imaging and diagnostic data together across radiology, cardiology, pathology, and other specialties. The company’s central argument at the conference was that fragmented diagnostic data, spread across multiple viewers, logins, and specialty workflows, creates avoidable clinical friction that a unified platform approach can reduce.

Philips also announced a cloud-enabled digital pathology solution built on Amazon Web Services as part of its HealthSuite Integrated Diagnostics portfolio, extending its enterprise imaging ambitions into pathology — a category that has lagged radiology in AI-driven workflow modernization. Philips’ Future Health Index 2025, cited at the conference, found that 77% of healthcare professionals have lost clinical time due to incomplete or inaccessible patient data, framing the connectivity challenge as a workforce issue as much as a technical one.

GE HealthCare Advances the Cloud-Native Radiology Workspace

GE HealthCare brought one of the most comprehensive imaging portfolios to HIMSS26, centering its showcase on Genesis Radiology Workspace, a next-generation platform designed to unify the radiologist experience across facilities and modalities. At the core is Genesis View, a zero-footprint diagnostic viewer accessible from any location, designed to extend subspecialty interpretation beyond the walls of academic medical centers to community hospitals lacking on-site specialists.

The company also highlighted Imaging 360, a platform for imaging operations management, and Command Center, its AI-enabled patient flow and hospital operations solution used by nearly 500 hospitals globally. GE HealthCare additionally joined the HL7 Caliper FHIR Accelerator as a founding member, a coalition focused on enabling consistent real-time data exchange between medical devices and EHRs — a foundational step for connecting imaging data to broader clinical workflows.

According to the company, GE HealthCare now leads the FDA’s list of AI-enabled medical device authorizations with 115 clearances to date, a figure that reflects both the breadth of its imaging portfolio and the pace at which imaging AI has matured as a regulated product category.

“The future of healthcare depends on how effectively we remove complexity and empower clinicians.” — Scott Miller, CEO, Solutions for Enterprise Imaging, GE HealthCare

“The future of healthcare depends on how effectively we remove complexity and empower clinicians,” said Scott Miller, CEO of Solutions for Enterprise Imaging at GE HealthCare. “By anticipating what healthcare teams need next, we’re accelerating cloud and AI-enabled solutions that help them work smarter, make faster, better-informed decisions, and deliver more connected, accessible care.”

Fujifilm Targets the Full Imaging Enterprise

Fujifilm Healthcare Americas showcased two radiology workflow tools at HIMSS26 that reflect its evolving enterprise imaging strategy. Synapse AI Orchestrator is an open imaging workflow platform that uses a rules engine to route preferred AI algorithm results directly into Fujifilm’s Synapse Enterprise PACS, designed for health systems deploying algorithms from multiple AI vendors who need consistent workflow integration across their organization. Synapse Worklist Orchestrator automates study assignment and workload balancing across facilities and subspecialists.

The company also introduced Synapse One in North America for the first time at HIMSS26, a workflow solution designed specifically for outpatient imaging needs. Beyond radiology, Fujifilm noted expanded AI activity in cardiology, pathology, and non-imaging AI models — signaling an ambition to address the full diagnostic enterprise rather than radiology alone.

Bill Lacy, senior vice president for medical informatics global business at Fujifilm Healthcare Americas, described the broader transition underway in enterprise imaging at the conference. According to Lacy, cloud has meaningfully lowered the barrier to enterprise imaging adoption for smaller health systems that previously could not justify the cost of managing their own data centers and imaging hardware. He also noted that most health systems are still in the process of centralizing imaging workflows across departments beyond core radiology and cardiology, with vendor-neutral archive technology playing a key bridging role.

Brainomix Brings Stroke AI to Every Corner of WVU’s Network

The most clinically grounded imaging announcement at HIMSS26 came from Brainomix, an Oxford University spinout that announced the deployment of its Brainomix 360 Stroke platform across all 25 sites of the West Virginia University (WVU) Health System. The deployment marks the first time the entire WVU network has operated under a unified AI stroke imaging solution.

Brainomix 360 Stroke is a fully automated platform that analyzes CT, CTA, CTP, and MRI scans in real time to detect large-vessel occlusions and assess ischemic core volume, enabling faster treatment and transfer decisions. For a health system serving rural and community hospitals across West Virginia, the clinical stakes are high: stroke outcomes are acutely time-sensitive, and geographic disparities in access to specialist imaging assessment have historically disadvantaged patients at smaller facilities.

“WVU Medicine is committed to advancing patient care through technologies that support clinical decision making and improve the patient experience,” said Charles J. Barkey, Vice President of Information Technology for Northern Panhandle WVU Medicine Hospitals. “As part of this effort, we recently implemented Brainomix’s AI imaging platform across our network to help reduce time to treatment for potentially critical stroke types, including large-vessel occlusion.”

Dr. Muhammad Alvi, professor and medical director of WVU’s Stroke Program, added that the partnership “ensures that every patient, whether they arrive at our flagship academic medical centers or a regional community hospital, receives the same level of expert stroke assessment.” The WVU deployment is a concrete example of a use case that has long been promised for imaging AI — closing geographic care gaps — now operating at network scale.

Visage Imaging Advances Cloud PACS and Digital Pathology

Visage Imaging, a subsidiary of Pro Medicus Ltd., showcased Visage 7.1.20 at HIMSS26, including several capabilities first demonstrated at RSNA 2025. Visage 7 Web extends the platform’s ultrafast viewing to HTML5 browsers, enabling secure mobile viewing without a local client installation. Visage Chat+ adds team communication, note-taking, ticketing, and workflow visibility directly within the enterprise imaging environment. The company also demonstrated digital pathology clinical viewing across the full Visage 7 platform, including mobile and visionOS support.

Visage highlighted its in-viewer AI-powered reporting capabilities, including automated impression generation and error checking, positioning its One Platform architecture as an alternative to multi-vendor point solutions that require radiologists to navigate separate interfaces for different imaging modalities.

“Our differentiated Visage 7 architecture is AI optimized and purpose built for the cloud,” said Malte Westerhoff, PhD, Co-Founder and Global Chief Technology Officer of Visage. “We take great pride in inventing new workflows that deliver rapid improvements for customers, amplifying the speed, scale and simplicity of One Platform.”

Aidoc Makes the Clinical Case for AI at Scale

While enterprise imaging platforms dominated the exhibit floor, the most direct argument for clinical AI in imaging came from the Physicians’ Forum, where Aidoc global Chief Medical Officer Dr. Jesse Ehrenfeld — also a former president of the American Medical Association — delivered the opening keynote address titled “From Hype to Healing: Real-World AI Integration in Clinical Practice.”

Ehrenfeld used the platform to push back on the broader AI hype cycle with operational specificity. According to Ehrenfeld, Aidoc’s platform processes more than 200,000 CT scans per day across more than 1,600 hospitals in 19 countries, providing triage alerts for time-sensitive conditions including stroke, pulmonary embolism, and intracranial hemorrhage. The scale of that deployment puts Aidoc among the largest clinical AI imaging networks in operation globally.

“There’s a lot of hype out there. There’s so much massive stuff happening with agentic AI, foundation models — our heads are spinning.” — Dr. Jesse Ehrenfeld, Global CMO, Aidoc; former President, American Medical Association

“There’s a lot of hype out there,” Ehrenfeld said at the forum. “There’s so much massive stuff happening with agentic AI, foundation models — our heads are spinning.” His keynote framed the antidote to that complexity as closing the clinical loop: using AI not merely to flag findings, but to orchestrate real-time alerts that reach care teams with key images attached, at the moment a patient’s outcome can still be changed. In stroke care specifically, where patients lose millions of neurons per minute without treatment, Ehrenfeld argued that the difference between AI as a reporting tool and AI as an active orchestrator is the difference between a patient being rolled out of a hospital or walking out.

The Aidoc presence at the Physicians’ Forum, and the decision to lead with a former AMA president as its clinical spokesman, reflects a broader strategic positioning: as imaging AI moves from radiology reading rooms into emergency and critical care workflows, the conversation is increasingly being directed at physicians rather than IT departments.

A Market in Infrastructure Mode — with Analytics Catching Up

Taken together, the medical imaging story at HIMSS26 operates on two distinct but reinforcing levels. Enterprise imaging platform vendors — GE HealthCare, Fujifilm, Philips, and Visage — are building the cloud-native infrastructure and workflow orchestration layers that allow AI algorithms to be deployed, managed, and interoperated at health system scale. Pure-play clinical AI companies, led by Aidoc at HIMSS26 and represented more broadly by companies such as DeepHealth, RapidAI, and HOPPR, are developing the algorithms and deployment frameworks that run on top of that infrastructure.

HealthTech HotSpot covered DeepHealth’s expanded AI imaging portfolio and HOPPR’s purpose-built AI development platform for medical imaging extensively at RSNA 2025, where both companies made significant announcements. RapidAI’s deep specialization in neurovascular and pulmonary imaging AI, validated across thousands of peer-reviewed cases, represents the clinical evidence depth that enterprise procurement increasingly demands. While none of these companies made specific HIMSS26 announcements, their trajectories reflect the same market dynamics on display in Las Vegas: deployment at network scale, workflow integration over standalone algorithm delivery, and clinical outcomes data as the primary commercial differentiator.

The Brainomix-WVU deployment stands apart as the conference’s most patient-centered imaging story, pointing to where enterprise imaging AI ultimately delivers its value: not on the conference floor, but in the moment a rural emergency physician receives an AI-assisted stroke assessment that would otherwise have required a specialist hours away.

As health systems continue to rationalize imaging vendor relationships and seek platforms that span radiology, cardiology, and pathology under a unified data model, HIMSS26 suggested the vendors best positioned for the next phase are those that can bridge both layers — enterprise infrastructure and validated clinical AI — whether through platform integration, acquisition, or partnership.

Photo credit: HIMSS26


— This original article was created with AI support.


Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.